Hot Flash Remedy report
Enough protein Westerners are accustomed to getting their protein from meat. Some plant products, however, including vegetables, grains and fruit, also contain protein. A balanced fruit-and-vegetable diet supplies enough protein to meet daily adult requirements. Soy is high in protein, and soy products also reduce LDL (the bad cholesterol), lower blood pressure, and can reduce night sweats and hot flashes often associated with menopause.
Physical dependence and withdrawal occur with the chronic use of opioids, but they are not psychological phenomena and therefore are completely unrelated to addiction. Physical dependence means that withdrawal symptoms might occur if the drug is suddenly stopped. These symptoms include anxiety, irritability, alternating chills and hot flashes, excessive salivation, tearing eyes (lacrimation), runny nose, nausea, vomiting, abdominal cramps, insomnia, sweating (diaphoresis), and goose bumps (piloerection). Physical dependence is easily treated, thereby avoiding withdrawal, by gradually decreasing the daily doses of the opioid, for example, by 10 to 25 percent. Once a low daily dose of morphine (20 mg orally) is reached, the opioid can be discontinued without withdrawal symptoms occurring.
I've often heard women say that the change of life is one of the touchiest times in their lives. The body and mind that they have become accustomed to for 40+ years are now different and often unpredictable. This change is a natural transition in a woman's life as fertility comes to an end. Menopause refers to a point when a woman stops ovulating and menstruating. Pre- or perimenopause lasts about five to ten years before the last period. This transition is marked by irregular menstruation, showing the decline in your body's ovary production of the reproductive hormones estrogen and progesterone. Typically, the last period occurs around age 50. Hormone replacement therapy, or HRT, is the only satisfactory therapy that conventional medicine offers to relieve such symptoms as hot flashes. When estrogens are contraindicated because of a family history of breast cancer, other medications are prescribed to control symptoms. The variety of symptoms women experience include hot flashes,...
As to the objective signs of relative androgen deficiency, although a decrease of muscle mass and strength and a concomitant increase in central body fat and osteoporosis can most easily be objectified, they are not specific signs. Decreased libido and sexual desire, loss of memory, difficulty in concentration, forgetfulness, insomnia, irritability, depressed mood as well as decreased sense of well-being, are rather subjective feelings or impressions, less easily objectified and certainly difficult to differentiate from hormone-independent aging. Complaints of excessive sweating are not uncommon, whereas true hot flushes do occur in elderly men, although they are mainly prevalent in severe acquired hypogonadism such as under hormonal treatment for prostate cancer.
In comparison to hypogondism, the definition for an ideal dissociation is different in male contraception or PCa. For male contraception a reduction in gonadotrophins is necessary, for PCa protection it is desired. For PCa, an ideal dissociated androgen should have antagonistic action on the prostate, but maintaining agonistic effects on brain, muscle and bone, to avoid side effects, like hot flushes, loss of libido, mood disturbance, muscle wasting and osteopenia.
Eighty percent of women will experience hot flashes when they become menopausal. Other symptoms include night sweats, difficulty sleeping, memory loss, irritability, and mood changes. Later, most women will experience vaginal dryness. Sometimes urinary symptoms such as leakage, frequency, and urgency occur because of the loss of estrogen action on the urogenital tissues, which include the urethra and the supporting tissues around the bladder. Without estrogen these tissues may atrophy somewhat over time. The lack of ovarian hormones may also contribute to the development of osteoporosis, a gradual thinning of the bone that increases the risk of fractures. As estrogen decreases, blood lipids, especially cholesterol and LDL, increase. At one time it was thought that these changes contributed to the development of cardiovascular disease and that supplementation with estrogens in menopause would protect against heart disease. Recent data from large studies (WHI, HERS, which are discussed...
Other medications may alleviate some the symptoms of menopause. None are as effective as estrogen in reducing hot flashes, however. These medications include selective serotonin reuptake inhibitors (SSRIs, often used to treat depression) or a progestin hormone based medication called megestrol acetate (Megace). Megace can reduce hot flashes but does have the side effect of promoting weight gain. Another medication that is useful but not as effective as hormonal medications is clonidine (Catapres). Clonidine is used primarily to treat hypertension, but in some women it helps reduce hot flashes. It is usually administered in the form of a skin patch. Side effects can include dizziness or fatigue. Some women find there are certain triggers, such as stress or alcohol, that set off their hot flashes, and avoiding these triggers can reduce the hot flashes. Caffeine can also be a trigger for some women, drinking caffeinated beverages increases the number or severity of hot flashes, and...
Hypogonadism is separated into primary (dysfunction of the testis or ovary) or central (pituitary or hypothalamic). Clinical manifestations of hypogonadism in prepubertal children cause no symptoms, whereas in adolescents hypogonadism leads to delayed or absent pubertal development. In adult women, hypogonadism causes amenorrhea, infertility, loss of libido, vaginal dryness, and hot flashes. In men, hypogonadism leads to loss of libido, erectile dysfunction, and infertility. Causes of primary hypogonadism include genetic disposition, menopause, autoimmune reactions, viruses, radiation, and chemotherapeutic agents. Central hypogonadism is most often caused by pituitary adenomas. Through compression of the gland, these tumors can cause destruction of pituitary tissue or interference with GnRH input from the hypothalamus. Gonadotropin dysfunction is the second most common hor
The natural process of menopause has been getting comforting help from Oriental Medicine for centuries. As you've already read, diet, exercise, and a healthy outlook are key components of any comprehensive treatment plan. Hot flashes, dry skin, vaginal dryness, increased thirst, insomnia, forgetfulness, and anxiety are part of the deficient heart yin pattern in Oriental Medicine. The term deficient yin in this case often refers to the reduction in estrogen. The term heart addresses not only the organ itself, but the accompanying forgetfulness, insomnia, palpitations, and mood changes.
Hot flashes The most common adverse effects reported with LHRH agonist therapy include a disease flare-up during the first week of therapy, hot flashes, erectile impotence, decreased libido, and injection-site reactions.26 The disease flare-up is caused by an initial induction of LH and FSH by the LHRH agonist, leading to an initial phase of increased testosterone production, and manifests clinically as either increased bone pain or increased urinary symptoms.26 This flare reaction usually resolves after 2 weeks and has a similar onset and duration pattern for the depot LHRH products.39,40 Initiating an antiandrogen prior to the administration of the LHRH agonist and continuing for 2 to 4 weeks is a frequently employed strategy to minimize this initial tumor flare.27 Hot flushes Gynecomastia Hot flushes Hot Flushes
The advantages of bilateral orchiectomy are that it causes a quick drop in the testosterone level (the testosterone level drops to its lowest level by 3 to 12 hours after the procedure average is 8.6 hours ), it is a one-time procedure, and it is more cost effective than the shots, which require several office visits per year and are more expensive. The disadvantages of orchiectomy are those of any surgical procedure and include bleeding, infection, permanence, and scrotal changes. In men who have undergone bilateral orchiec-tomy and are bothered by an empty scrotum, bilateral testicular prostheses may be placed that are the same size as the adult testes. Most men who undergo bilateral orchiectomy lose their libido and have erectile dysfunction after the testosterone level is lowered. Other long-term side effects of bilateral orchiectomy, related to testosterone depletion, include hot flashes, osteoporosis, fatigue, loss of muscle mass, anemia, and weight gain. Breast tenderness and...
LHRH analogues and antagonists have side effects that may affect your quality of life over the short and long term (Table 9). Some of the side effects related to these medications, such as hot flashes, erectile dysfunction, anemia, and osteoporosis, can be treated. Erectile dysfunction occurs in about 80 of men taking LHRH analogues and antagonists and is associated with decreased libido (sexual desire). The widely prescribed drug silde-nafil (Viagra) as well as the other oral therapies for erectile dysfunction, vardenafil (Levitra) and tadalafil (Cialis) are effective in most of these men if they had normal erectile function before starting hormone therapy. Unfortunately, there is no medication to restore libido. A group of medications commonly used in women with osteoporosis are the biphosphonates, which prevent bone breakdown. Three different biphosphonates, ale-dronate (Fosamax), neridronate (Nerexia), and zole-dronate (Zometa) have been used to prevent osteoporosis in...
Over the past decade, new information has been published regarding the use of a new generation of aromatase inhibitors. These data have changed the way we treat metastatic breast cancer, as well as early-stage breast cancer (as noted previously). In postmenopausal and castrated women, the main source of estrogen is derived from the peripheral conversion of androstenedione, produced by the adrenal gland, to estrone and estradiol. This conversion requires the enzyme aromatase. Aromatase also catalyzes the conversion of androgens to estrogens in the ovary in premenopausal women and in extraglandular tissue, including the breast itself, in postmenopausal women. Therefore, aromatase inhibitors (e.g., anastrozole, letrozole, and exemestane) effectively reduce the level of circulating estrogens, as well as estrogens in the target organ. Their toxicity profile consists mainly of nausea, hot flashes, arthralgias myalgias, and mild fatigue. Anastrozole and letrozole are nonsteroidal compounds...
Therapeutic modalities for amenorrhea are targeted at restoring the normal menstrual cycle. The goals of treatment are to preserve bone density, prevent bone loss, and restore ovulation, thus improving fertility as desired. Amenorrhea resulting from conditions contributing to hypoestrogenism also may affect quality of life via the induction of hot flashes (premature ovarian failure), dyspareunia, and in prepubertal females, lack of secondary sexual characteristics, and absence of menarche.
BW, a 50-year-old woman with a history of osteoarthritis and hypothyroidism, presents to the clinic complaining of hot flashes, vaginal dryness, and insomnia. She states that she experiences approximately two hot flashes per day and is awakened from sleep at least three to four times a week in a pool of sweat requiring her to change her clothes and bed linens. Her symptoms began about 3 months ago, and over that time, they have worsened to the point where they have become very bothersome. On questioning, she states her last menstrual period was 1 year ago.
Evaluating the outcomes of any therapy for menopausal symptoms focuses primarily on the woman's report of symptom resolution. Ask women to report the resolution or reduction of hot flashes, night sweats, and vaginal dryness, and any improvement or change in sleep patterns. Also ask women taking hormonal therapies to report any
Women suffering from vasomotor symptoms should attempt lifestyle or behavioral modifications before seeking medical treatment. Women who seek medical treatment usually suffer from symptoms that diminish their QoL, such as multiple hot flashes per day or week, sleep disturbances, vaginal dryness, or mood swings. HT should be considered for these women, but is not the most appropriate choice for all women.
Endometriosis can be a stubborn and frustrating condition because of the complex interplay of hormones and unknown scarring and adhesions. Dr. Joel Hargrove, of Vanderbilt, Tennessee, has spent many years studying the effects of endometriosis. He states that PMS is reported by 80-90 percent of women with endometriosis. Conventional medical treatment is controversial and must be individualized. Medications are often prescribed to suppress ovarian function. Oral contraceptives may also be used in an attempt to prevent the proliferation of endometriosis. Side effects of suppressive medications, such as danazol, are often unpleasant and include weight gain, fluid retention, fatigue, decreased breast size, acne, hot flashes, and muscle cramps.
This B-vitamin is also involved in energy-producing reactions in the cells that convert food to energy. In addition, niacin helps maintain healthy skin, nerves, and your digestive system. In some instances, you can use large doses of niacin as a cholesterol-lowering medication. However, you should only do this under the supervision of your doctor. Megadoses can cause hot flashes, itching, ulcers, high blood sugar, and liver damage.
Use Some women take this for PMS and menopausal symptoms, but nothing has been clinically verified in humans. (However, it is big in Europe.) It suppresses the leutinizing hormone and therefore helps control hormone surges that cause discomforting menopausal symptoms. Relieving physical symptoms can lead to improving the emotional symptoms. In other words, some women get entirely depressed because they feel so physically lousy. Improve the hot flushes, bloating, etc., and the depression can sometimes improve.
Estrogens have also been used to decrease bleeding time. The onset of action is slower than that of DDAVP, but more sustained, and it depends on the route of administration. IV doses of 0.6 mg kg day for 4 to 5 days decreases bleeding time within 6 hours of administration, and produces an effect that lasts up to 2 weeks after stopping therapy. The onset of action with oral doses of 50 mg kg daily is within 2 days of treatment and is sustained for 4 to 5 days after stopping therapy. Transdermal patches providing 50 to 100 mcg day have also been shown to be effective in decreasing bleeding time.63 Side effects of estrogen use include hot flashes in both females and males, fluid retention, and hypertension.